Author: Yu, Lan; Tian, Xun; Gao, Chun; Wu, Ping; Wang, Liming; Feng, Bei; Li, Xiaomin; Wang, Hui; Ma, Ding; Hu, Zheng
Title: Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas Cord-id: 4ky9tu5x Document date: 2018_4_12
ID: 4ky9tu5x
Snippet: Viral infections cause at least 10%–15% of all human carcinomas. Over the last century, the elucidation of viral oncogenic roles in many cancer types has provided fundamental knowledge on carcinogenetic mechanisms and established a basis for the early intervention of virus-related cancers. Meanwhile, rapidly evolving genome-editing techniques targeting viral DNA/RNA have emerged as novel therapeutic strategies for treating virus-related carcinogenesis and have begun showing promising results.
Document: Viral infections cause at least 10%–15% of all human carcinomas. Over the last century, the elucidation of viral oncogenic roles in many cancer types has provided fundamental knowledge on carcinogenetic mechanisms and established a basis for the early intervention of virus-related cancers. Meanwhile, rapidly evolving genome-editing techniques targeting viral DNA/RNA have emerged as novel therapeutic strategies for treating virus-related carcinogenesis and have begun showing promising results. This review discusses the recent advances of genome-editing tools for treating tumorigenic viruses and their corresponding cancers, the challenges that must be overcome before clinically applying such genome-editing technologies, and more importantly, the potential solutions to these challenges.
Search related documents:
Co phrase search for related documents- aav deliver and acute sars cov respiratory syndrome coronavirus: 1
- aav vector and activation response: 1
Co phrase search for related documents, hyperlinks ordered by date